Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

ACR Image Competition 2022 Results, Part 1

Lauren Harper, MD  |  Issue: December 2022  |  

Click to enlarge.

Tongue Twister

12-year-old girl who had been diagnosed with Moebius syndrome a year earlier presented for evaluation of progressive tongue hemiatrophy that was causing her difficulty with eating and speaking. Magnetic resonance imaging (MRI) of the brain demonstrated tongue hemiatrophy without involvement of the hypoglossal nerve. A tongue biopsy showed atrophy of skeletal muscle, variably sized nerves, stromal calcification, mild hyperplasia of overlying mucosa, parakeratosis and mild subepithelial inflammation. The patient had forehead and post-auricular skin discoloration.

She was diagnosed with Parry-Romberg syndrome and en coup de sabre localized scleroderma. This rare complication of scleroderma can result in cosmetic disfigurement and functional impairments with speech and eating if diagnosis is delayed.

ADVERTISEMENT
SCROLL TO CONTINUE

Lauren Harper, MD, is a rheumatology fellow at Nationwide Children’s Hospital, Columbus, Ohio. She earned her medical degree at Loma Linda University School of Medicine, California and completed her residency at Loma Linda University Medical Center.

About the Contest

The Rheumatology Image Library is a highly accessed teaching resource. The 2022 Image Competition sought images representing a diverse range of patients who show either characteristic or unusual manifestations of rheumatic disease, including systemic sclerosis, localized scleroderma and scleroderma mimics. In addition to the Best Overall Image, winning images were selected from five regions across the world.

ADVERTISEMENT
SCROLL TO CONTINUE

 

   Here, we present the image featured from North America. Look for the People’s Choice and other regional winners in future issues or in the Rheumatology Image Library.

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    The History of the American College of Rheumatology Image Library

    Late-night gatherings; long hours of avid discussion weighing the merits of resolution quality, light, hues and tones; and camaraderie among members forged through a shared interest in maintaining the highest fidelity to their craft and profession—these are among the vivid memories of those who participated in the early years of building what is today known…

    Study Probes New Gene Therapy for Severe, Localized Scleroderma (Morphea)

    In September 2018, the U.S. Food & Drug Administration (FDA) granted fast-track status to FCX‑013, a gene therapy product developed to treat moderate to severe localized scleroderma (morphea). Previously, the treatment received an orphan drug designation for localized scleroderma, as well as a rare pediatric disease designation. Phase 1 and 2 studies will assess safety…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….